Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Vascular complications are the leading cause of death in diabetic patients worldwide. Adverse micro- and macrovascular changes, which may occur early in diabetes mellitus (DM), are a major problem faced by these patients. This includes accelerated incidence of atherosclerosis, stroke, peripheral artery disease, retinopathy, nephropathy and coronary disease leading to myocardial infarction (MI) [1]. In recent years, progress in diabetes research has resulted in development of a series of anti-hyperglycemic drugs that successfully control glucose levels in most DM patients. However, these new treatments may not avert the onset of vascular complications. Alternative therapeutic strategies are clearly needed.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi